Kezar Life Sciences, Inc. (KZR) Tops Q3 EPS by 5c

Kezar Life Sciences, Inc. (NASDAQ: KZR) reported Q3 EPS of ($0.25), $0.05 better than the analyst estimate of ($0.30).

For earnings history and earnings-related data on Kezar Life Sciences, Inc. (KZR) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
• SanDisk upgraded at JPMorgan after investor day; shares climb